Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2024, Cilt: 49 Sayı: 2, 299 - 316, 25.08.2024
https://doi.org/10.55262/fabadeczacilik.1415284

Öz

Kaynakça

  • Rençber S, Karavana SY, Yılmaz FF, Eraç B, Nenni M, Özbal S, Pekçetin Ç, Gurer-Orhan H, Hoşgör-Limoncu M, Güneri P, Ertan G. (2016). Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. International Journal of Nanomedicine, 11, 2641-53.

Linezolid Loaded Nanoparticle for Topical Administration of Diabetic Foot Treatment: Formulation, In Vitro and Ex Vivo Characterization

Yıl 2024, Cilt: 49 Sayı: 2, 299 - 316, 25.08.2024
https://doi.org/10.55262/fabadeczacilik.1415284

Öz

The aim of this research work was to develop a topical gel formulation containing nanoparticle to diabetic foot ulcer (DFU). In this respect, the nanoparticle formulations were prepared by using spontaneous emulsification technique. The linezolid (LZD) loaded nanoparticle formulation exhibited an low average particle size (PS) of 195.27±5.42 nm, low polydispersity index (PI) of 0.214±0.019, a high zeta potential (ZP) of 20.57±0.35 and high drug entrapment efficiency (EE) of 99.746±0.021%. In order to enhance topical residence time, the LZD-loaded nanoparticles were dispersed in a gel formulation using Methocel TM K4M (HPMC) and Carbopol® 974 P NF. The formulated gels demonstrated favorable characteristics, including an appropriate pH value, suitable mechanical performance, and desirable viscosity and spreadability for topical administration. All formulations displayed pseudoplastic flow and exhibited typical gel-type mechanical spectra at the specified frequency value. Moreover, the developed formulation achieved sustained drug release as intended for these systems. During the ex vivo drug diffusion studies, 0.007±0.004% of LZD was found in receptor phase, and this was an indicator of local effect. The optimum formulation was stable for 6 months. The initial findings suggest that the formulated topical gel containing LZD-loaded nanoparticles holds promise as an effective drug delivery system for DFU management. However, further comprehensive investigations are required to substantiate this hypothesis.

Destekleyen Kurum

Scientific and Technological Research Council of Turkey (TUBITAK–2209-A)

Teşekkür

The authors wish to thank MS Pharma-Turkey for gift sample of LZD. The authors would like to thank to Scientific and Technological Research Council of Turkey (TUBITAK–2209-A) for their support of the project.

Kaynakça

  • Rençber S, Karavana SY, Yılmaz FF, Eraç B, Nenni M, Özbal S, Pekçetin Ç, Gurer-Orhan H, Hoşgör-Limoncu M, Güneri P, Ertan G. (2016). Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis. International Journal of Nanomedicine, 11, 2641-53.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular İlaç Dağıtım Teknolojileri
Bölüm Araştırma Makalesi
Yazarlar

Yusuf Polat Bu kişi benim 0009-0004-5071-9803

Hüsniye Hande Aydın Bu kişi benim 0000-0002-4296-3628

Seda Rençber 0000-0003-0172-2120

Yayımlanma Tarihi 25 Ağustos 2024
Gönderilme Tarihi 26 Ocak 2024
Kabul Tarihi 19 Nisan 2024
Yayımlandığı Sayı Yıl 2024 Cilt: 49 Sayı: 2

Kaynak Göster

APA Polat, Y., Aydın, H. H., & Rençber, S. (2024). Linezolid Loaded Nanoparticle for Topical Administration of Diabetic Foot Treatment: Formulation, In Vitro and Ex Vivo Characterization. Fabad Eczacılık Bilimler Dergisi, 49(2), 299-316. https://doi.org/10.55262/fabadeczacilik.1415284